PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Mei Ma

School of Pharmacy, Ningxia Medical University, 1160 Shengli Street, 750004 Yinchuan, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

JUL 2, 2026 · JOURNAL ARTICLE

Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer.

International Journal of Pharmaceutics: X

Preclinical murine model study demonstrates nanoplatform remodels tumor microenvironment and enhances immune checkpoint blockade efficacy in triple-negative breast cancer.

PromisingDi Cao Haiwang Luo Jing Wang

Study details

DesignPreclinical in vitro and in vivo study

InterventionErythrocyte membrane-camouflaged biomimetic…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support